Adolfo Calderon

Medical Student at UABC, Tijuana, México🫀 Medical Intern at INCMNSZ, Mexico 🫀Aspirant to Cardiology🫀

[Adolfo Calderon @MDAdolfoCald]

@VJHemOnc @UABC_oficial Great Interview with @VJHemOnc
Thanks for the invitation!!!
#Cardiology #ATTR-CM

[VJHemOnc @VJHemOnc]

ESC 2026 | Adolfo Calderón Fernández of @UABC_oficial just shared insights into the comparative effectiveness of silencers vs stabilizers in ATTR-CM, key differences across clinical outcomes, and emerging therapies that could shape the future of cardiac #Amyloidosis treatment.

Coming soon to https://t.co/Vqyt4af67F! 🎥

#HemOnc #CardioOnc #CardioOncology

[Adolfo Calderon @MDAdolfoCald]

Proud of my team for representing our work at ACC 2026 in New Orleans. It’s incredibly rewarding to see our research presented on such an important stage. Grateful for the dedication, teamwork, and commitment behind each project. Looking forward to what’s ahead.

[Adolfo Calderon @MDAdolfoCald]

Proud to share that our team presented 5 research projects at the ACC Annual Scientific Session 2026 in New Orleans 🫀🩺
Grateful for the opportunity to contribute and connect with the cardiology community 🫀🩺

#NOLA #Cardiology #ACC #AmericanCollegeofCardiology

[Adolfo Calderon @MDAdolfoCald]

Great Experiences with Great People!🫀🩺
It’s an honor and a pleasure sharing these moments with you 🫀🩺
The family that research gave me!!! 🫀🩺
#AHA25 #Research #Cardiology

[Adolfo Calderon @MDAdolfoCald]

Excited to participate in #AHA25 where our collaborative team will present 7 presentations in interconnected disciplines 🩺🫀
Bring your questions and join the dialogue 🩺🫀
See you at New Orleans!!! 🩺🫀
#Cardiology #researcher #LatinoAmerica

[Mayra Guerrero, MD @MayraGuerreroMD]

This is a truly historic moment. The results from this pivotal trial evaluating a fully percutaneous transcatheter mitral valve replacement technology has opened a new treatment option for patients who are not good candidates for surgery or TEER. This is a remarkable milestone that will not only transform the field of interventional cardiology but, most importantly, will change the lives of countless patients who have been waiting for a viable treatment option. Slides presented as LBCT #TCT2025 today and link to our manuscript published @TheLancet today are included. Thank you to all the people who worked with us for a decade to make this happen! @DVDaniels @MayoClinicCV

https://t.co/ufEseWlevp

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

What everyone needs to read: @JACCJournals:

Global Burden of CVD

🚨CVD remains the leading cause of disease burden & death worldwide with geographic variations
🫀CVD burden: explained substantially by known, modifiable risk factors that are inadequately controlled- particularly metabolic risk!
🫀The decades-long ⤴️ in CVD burden is due to population growth, population aging, & ⤴️ exposure to metabolic risks
🌎 ALL Countries need to adopt effective health system & public health strategies to ⤵️ burden of CVD which means more preventative strategies ♥️

📎 https://t.co/xq1LFV853j

#CVPrev #GlobalBurden #CVD @ACCinTouch @AgarwalRajivMD @DBelardoMD @adribaran @mmamas1973 @KatherineTuttl8 @HeartOTXHeartMD

[JACC Journals @JACCJournals]

Fibrinolytic therapy remains a major mgmt option for thromboembolic diseases. Advances in catheter-directed techniques, dosing strategies, & novel agents may expand therapeutic options & improve the safety of fibrinolytic therapy. https://t.co/pTAdP6G1oc #JACC @bbikdeli @hmkyale

[Adolfo Calderon @MDAdolfoCald]

It is a pleasure to share that the Cardiology Interest Group by American College of Cardiology from my Institution, of which I am a founder, is getting national and international recognition 🫀🩺
Congratulations mis niñes 🫀🩺
#Cardiology #Medstudent #LatinAmerica #ACC

[Adolfo Calderon @MDAdolfoCald]

Last weekend, I had the pleasure of presenting 1 oral presentation and 3 posters at the American College of Cardiology Latin America congress in Mexico City 🫀🩺
It was an honor representing my institution in a international congress 🫀🩺
#Cardiology #LatinAmerica #ResearchConf

[Adolfo Calderon @MDAdolfoCald]

Thrilled to share my latest publication in JACC: Case Reports:
🔗 https://t.co/he2n0jDRYV

Grateful to my co-authors and the scientific community for the support. Hoping this work sparks further discussion and research in this field.

[Adolfo Calderon @MDAdolfoCald]

Honored to be presenting at ACC Latin America 2025 🇲🇽. I’ll share an oral presentation on Sotatercept in PAH and several poster presentations on key cardiovascular topics. Proud to represent our team at such a prestigious congress! #ACC #Cardiology #Latam #ResearchConf

[Adolfo Calderon @MDAdolfoCald]

Proud to share that I’ll be presenting a Moderated Poster Presentation at the AHA 2025 Scientific Sessions in New Orleans🫀🩺
Even more proud of the incredible work of my colleagues—together, we submitted and will be presenting 6 abstracts at this prestigious congress🫀🩺

[Adolfo Calderon @MDAdolfoCald]

Grateful and proud to have represented the Universidad Autónoma de Baja California at ACC25 in Chicago, Illinois, where I presented three research projects — two as posters and one as an poster moderated presentation 🫀🩺

[Adolfo Calderon @MDAdolfoCald]

Proud to share my first scientific publication. 🫀

This is just the beginning of a long journey in medicine and research, now as a medical intern. 🫀

Thanks to @drlizapompa for her support and coordination 🫀

Doi: 10.1016/j.radcr.2025.04.096